G. Batista

SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

F. Cunha, T. Cunha, A. Figueira, 2019, Cancer Chemotherapy and Pharmacology.

The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis

F. Cunha, R. Ribeiro, G. Brito, 2015, PloS one.

Topical protection of mice laryngeal mucosa using the natural product cashew gum

D. Sifrim, J. Medeiros, P. Soares, 2018, The Laryngoscope.